Results 191 to 200 of about 25,820 (298)

PUK8 THE COST-EFFECTIVENESS OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)

, 2009
MS Keith, Rashad Carlton, BL Meissner
openalex   +1 more source

Tenapanor: A novel therapeutic agent for dialysis patients with hyperphosphatemia. [PDF]

Ther Apher Dial
Akizawa T, Urano N, Ikejiri K, Nakanishi K, Fukagawa M.   +4 more
europepmc   +1 more source

Safety and efficacy of pemigatinib in patients with cholangiocarcinoma: a systematic review. [PDF]

J Gastrointest Oncol
Rasool W, Alami Idrissi Y, Ahmad O, Rath S, Saeed F, Sayed MS, Sharma B, Ibrahim AA, Kumari A, Ullah I, Saeed A.   +10 more
europepmc   +1 more source

Genetic diseases resulting from disordered FGF23/klotho biology [PDF]

, 2017
Econs, Michael J.
core   +1 more source

Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report. [PDF]

Oncologist
Galli-Vareia I, Szturz P, Voutsadakis IA, Villard N, Tsoumakidou G, Fleury M, Herrera G, Fasquelle F, Godat S, Digklia A.   +9 more
europepmc   +1 more source

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats. [PDF]

Sci Rep
Anegkamol W, Bowonsomsarit W, Taweevisit M, Tumwasorn S, Thongsricome T, Kaewwongse M, Pitchyangkura R, Tosukhowong P, Chuaypen N, Dissayabutra T.   +9 more
europepmc   +1 more source

MP392IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS [PDF]

, 2016
Yuriy Milоvanоv, Anna Dudareva, Ludmilа Milоvаnоvа, Lidia Kozlovskaya, Н А Мухин, Marina Lebedeva   +5 more
openalex   +1 more source

Biomimetic wrinkled prebiotic microspheres with enhanced intestinal retention for hyperphosphatemia and vascular calcification. [PDF]

Sci Adv
Hu B, Wang Y, Yu L, Cao L, Liu S, Zhong L, Wang G, Qiu X, Hou H.   +8 more
europepmc   +1 more source

Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study. [PDF]

BMC Nephrol
Chaiyakittisopon K, Pattanaprateep O, Ponthongmak W, Kunakorntham P, Chuasuwan A, Ingsathit A, Mckay GJ, Attia J, Thakkinstian A.   +8 more
europepmc   +1 more source

A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients. [PDF]

Kidney Int Rep
Wang L, Zuo L, Shi M, Gu L, Ma K, Wang P, Wang Y, Luo Q, Chen M, Zhang P, Jiang H, Li G, Zhang W, Liu YC, Zhao Q.   +14 more
europepmc   +1 more source